Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BARICITINIB vs BECAPLERMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BARICITINIB vs BECAPLERMIN: Safety Overview

Metric BARICITINIB BECAPLERMIN
Total FAERS Reports 8,108 2,059
Deaths Reported 717 69
Death Rate 8.8% 3.4%
Hospitalizations 2,498 476
Average Patient Age 58.2 yrs 64.0 yrs
% Female Patients 67.9% 39.6%
FDA Approval Date Aug 8, 2025 N/A
Manufacturer Eli Lilly and Company N/A
Route ORAL N/A
Marketing Status Prescription Prescription